Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds JP Morgan Downgrades Vroom to Underweight

JP Morgan Downgrades Vroom to Underweight

JP Morgan analyst Rajat Gupta downgrades Vroom (NASDAQ:VRM) from Neutral to Underweight.

byBenzinga Newsdesk

August 15, 2022

1 minute read

JP Morgan analyst Rajat Gupta downgrades Vroom (NASDAQ:VRM) from Neutral to Underweight.

FDA
News

Y-mAbs Announces Complete Response Letter For Omburtamab Biologics License Application

By Michael Horton

December 1, 6:36 PM

Y-mAbs Therapeutics, Inc. (the "Company" or "Y-mAbs") (NASDAQ:YMAB) a commercial-stage biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic

YMAB

News

Castle Biosciences Receives Accreditation From The College Of American Pathologists For Its Pittsburgh Clinical Laboratory

By Benzinga Newsdesk

November 21, 8:09 AM

Castle Biosciences, Inc. (NASDAQ:CSTL), a company improving health through innovative tests that guide patient care, today announced that the Accreditation Committee of the College of American Pathologists (CAP) has

CSTL

AIM ImmunoTech Announces Abstract Accepted For Poster Presentation At British Society For Immunology Congress 2022 Dec. 7

By Benzinga Newsdesk

December 2, 11:46 AM

Poster No: P-220 Title: Safety, tolerability and biological activity of repeated intranasal administration of TLR3 agonist Ampligen (Poly I:Poly C12U) in healthy subjects Presenter: Lisanne C.A. Smidt -

AIM